These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33124617)

  • 1. Validation and Implementation of a Highly Sensitive and Efficient Newborn Screening Assay for Mucopolysaccharidosis Type II.
    Bilyeu H; Washburn J; Vermette L; Klug T
    Int J Neonatal Screen; 2020 Oct; 6(4):. PubMed ID: 33124617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence and recommendation for mucopolysaccharidosis type II newborn screening in the United States.
    Ream MA; Lam WKK; Grosse SD; Ojodu J; Jones E; Prosser LA; Rosé AM; Comeau AM; Tanksley S; Powell CM; Kemper AR
    Genet Med; 2023 Feb; 25(2):100330. PubMed ID: 36445366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type II.
    Johnson BA; van Diggelen OP; Dajnoki A; Bodamer OA
    Curr Protoc Hum Genet; 2013 Oct; 79():17.14.1-17.14.9. PubMed ID: 24510650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for hunter disease: a small-scale feasibility study.
    Ruijter GJ; Goudriaan DA; Boer AM; Van den Bosch J; Van der Ploeg AT; Elvers LH; Weinreich SS; Reuser AJ
    JIMD Rep; 2014; 14():23-7. PubMed ID: 24272678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel fluorometric enzyme analysis method for Hunter syndrome using dried blood spots.
    Tolun AA; Graham C; Shi Q; Sista RS; Wang T; Eckhardt AE; Pamula VK; Millington DS; Bali DS
    Mol Genet Metab; 2012 Mar; 105(3):519-21. PubMed ID: 22227323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan.
    Hattori Y; Sawada T; Kido J; Sugawara K; Yoshida S; Matsumoto S; Inoue T; Hirose S; Nakamura K
    Mol Genet Metab Rep; 2023 Dec; 37():101003. PubMed ID: 38053932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brazilian reference values for MPS II screening in dried blood spots--a fluorimetric assay.
    Rezende MM; Müller KB; Pereira VG; D'Almeida V
    Clin Biochem; 2014 Sep; 47(13-14):1297-9. PubMed ID: 24979053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform.
    Sista RS; Wang T; Wu N; Graham C; Eckhardt A; Winger T; Srinivasan V; Bali D; Millington DS; Pamula VK
    Clin Chim Acta; 2013 Sep; 424():12-8. PubMed ID: 23660237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct assay of iduronate-2-sulfatase for Hunter disease using UPLC-tandem mass spectrometry and fluorogenic substrate.
    Lee K; Jun SH; Song SH; Park HD; Park KU; Song J
    Clin Biochem; 2015 Dec; 48(18):1350-3. PubMed ID: 26297117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the relationship between clinical phenotypes and plasma iduronate-2-sulfatase enzyme activities in Hunter syndrome patients.
    Lee OJ; Kim SJ; Sohn YB; Park HD; Lee SY; Kim CH; Ko AR; Yook YJ; Lee SJ; Park SW; Kim SH; Cho SY; Kwon EK; Han SJ; Jin DK
    Korean J Pediatr; 2012 Mar; 55(3):88-92. PubMed ID: 22474463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexing Iduronate-2-Sulphatase (MPS-II) into a 7-Plex Lysosomal Storage Disorder MS/MS Assay Using Cold-Induced Phase Separation.
    Courtney E; Pickens CA; Cuthbert C; Petritis K
    Int J Neonatal Screen; 2023 Jun; 9(2):. PubMed ID: 37367213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.
    Kosuga M; Mashima R; Hirakiyama A; Fuji N; Kumagai T; Seo JH; Nikaido M; Saito S; Ohno K; Sakuraba H; Okuyama T
    Mol Genet Metab; 2016 Jul; 118(3):190-197. PubMed ID: 27246110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for mucopolysaccharidosis II (Hunter disease).
    Wang D; Wood T; Sadilek M; Scott CR; Turecek F; Gelb MH
    Clin Chem; 2007 Jan; 53(1):137-40. PubMed ID: 17082248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mucopolysaccharidosis type II by measurement of iduronate-2-sulfatase in dried blood spots and plasma samples.
    Dean CJ; Bockmann MR; Hopwood JJ; Brooks DA; Meikle PJ
    Clin Chem; 2006 Apr; 52(4):643-9. PubMed ID: 16497940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis II (Hunter Syndrome).
    Wolfe BJ; Blanchard S; Sadilek M; Scott CR; Turecek F; Gelb MH
    Anal Chem; 2011 Feb; 83(3):1152-6. PubMed ID: 21192662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a HIR-Fab-IDS, Novel Iduronate 2-Sulfatase Fusion Protein for the Treatment of Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome).
    Gusarova VD; Smolov MA; Lyagoskin IV; Degterev MB; Rechetnik EV; Rodionov AV; Pantyushenko MS; Shukurov RR
    BioDrugs; 2023 May; 37(3):375-395. PubMed ID: 37014547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening for Morquio disease and other lysosomal storage diseases: results from the 8-plex assay for 70,000 newborns.
    Chien YH; Lee NC; Chen PW; Yeh HY; Gelb MH; Chiu PC; Chu SY; Lee CH; Lee AR; Hwu WL
    Orphanet J Rare Dis; 2020 Feb; 15(1):38. PubMed ID: 32014045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Two Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis Type II.
    Herbst ZM; Urdaneta L; Klein T; Burton BK; Basheeruddin K; Liao HC; Fuller M; Gelb MH
    Int J Neonatal Screen; 2022 Jan; 8(1):. PubMed ID: 35225932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn Screening Program for Mucopolysaccharidosis Type II and Long-Term Follow-Up of the Screen-Positive Subjects in Taiwan.
    Lin HY; Chang YH; Lee CL; Tu YR; Lo YT; Hung PW; Niu DM; Liu MY; Liu HY; Chen HJ; Kao SM; Wang LY; Ho HJ; Chuang CK; Lin SP
    J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.